KELUN PHARMA(SZ:002422) Nan Fang Du Shi Bao·2025-05-15 08:41Core Viewpoint - The chairman of Kelun Pharmaceutical, Liu Gexin, has gained attention through a promotional video for the company's ergothioneine capsules, showcasing his fitness at the age of 75, which has sparked discussions about the product's efficacy and authenticity [2][4][10]. Company Response - Kelun Pharmaceutical confirmed that the video featuring Liu Gexin is authentic and not digitally altered, emphasizing the chairman's commitment to a healthy lifestyle and the product's role in promoting health [4][6]. - The company stated that Liu has been taking ergothioneine capsules for three consecutive years while maintaining a fitness and reading routine, attributing his physical condition to a combination of lifestyle choices and the supplement [6][8]. Business Strategy - Liu Gexin announced a new venture into the anti-aging sector, marking it as his "fourth entrepreneurial journey" after previous successes in intravenous solutions, antibiotics, and innovative drugs [6][8]. - The company aims to establish an ecological platform for anti-aging, focusing on ergothioneine as a key product while expanding into other active anti-aging molecules and health supplements over the next three to five years [8][9]. Product Details - The ergothioneine capsules are priced at 1499 yuan for 60 capsules, marketed as a dietary supplement with claims of superior antioxidant effects compared to traditional ingredients [11][16]. - The product is produced in collaboration with a century-old Japanese pharmaceutical company, ensuring high-quality standards and global sales rights outside Japan [15][16]. Market Context - The anti-aging market in China is rapidly growing, with the silver economy projected to reach 12.3 trillion yuan by 2028, highlighting the potential for companies like Kelun to capitalize on this trend [18]. - Kelun Pharmaceutical is recognized as a leading player in the domestic pharmaceutical industry, with a comprehensive product range and a strong market position [17]. Research and Development - The company is actively conducting research on ergothioneine, with positive preliminary results from animal studies and user feedback indicating benefits such as improved sleep and increased energy [18][19]. - Kelun plans to collaborate with medical institutions for clinical trials to further validate the efficacy of its anti-aging products [18].